NCT06509425

Brief Summary

Permanent tubal sterilization during Caesarean section is a reliable method of contraception. It is done either by bilateral tubal ligation or bilateral salpingectomy according to surgeon's preference. Studies revealing bilateral salpingectomy has an added benefit of primary prevention of ovarian cancer has encouraged surgeons to perform bilateral salpingectomy rather than tubal ligation as a risk reducing surgery owing to the acceptance of fallopian tubes as the origin of high grade serous ovarian cancer. Another aspect to take into consideration is the post tubal ligation syndrome as it severely affects the quality of life. Diagnosis is based on clinical picture, imaging, and exclusion of other causes of chronic pelvic pain. Women experience dysmenorrhea, dyspareunia, menstrual irregularities, and pelvic pain. The gold standard is venography; however, the first choice for initial evaluation is duplex ultrasound. In this study, we assess impact of bilateral salpingectomy versus tubal ligation in terms of pelvic congestion by participant's symptoms and ultrasound findings

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2024

Completed
28 days until next milestone

Study Start

First participant enrolled

May 21, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 19, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

July 19, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

April 23, 2024

Last Update Submit

July 13, 2024

Conditions

Keywords

salpingectomypelvic congestiontubal ligation

Outcome Measures

Primary Outcomes (1)

  • symptoms of pelvic congestion syndrome

    A questionnaire to detect changes in menstrual pattern or new onset of pelvic pain.

    Ten weeks postoperative

Secondary Outcomes (2)

  • signs of pelvic congestion syndrome

    Ten weeks postoperative

  • intraoperative complications

    intraoperative

Study Arms (2)

Participants undergoing caesarean section and salpingectomy.

ACTIVE COMPARATOR
Procedure: salpingectomy during caesarean section

Participants undergoing caesarean section and tubal ligation

ACTIVE COMPARATOR
Procedure: tubal ligation during caesarean section

Interventions

Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.

Participants undergoing caesarean section and salpingectomy.

Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.

Participants undergoing caesarean section and tubal ligation

Eligibility Criteria

Age30 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females undergoing caesarean section and requesting tubal sterilization as a permanent method of contraception.
  • years or older

You may not qualify if:

  • Previous history of tubal surgery (changes in blood flow)
  • Previous history of oophorectomy (changes in blood flow)
  • Congenital anomalies or malformations in fallopian tubes or ovaries. (affection of normal anatomy of pelvic blood vessels)
  • Women diagnosed with pelvic congestion. (Known cause for pelvic congestion other than tubal sterilization)
  • High likelihood of lost to follow up.
  • Inability to provide good data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams Maternity Hospitals

Cairo, Abaseya, 11588, Egypt

RECRUITING

Central Study Contacts

Mayar Z Kamal

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2024

First Posted

July 19, 2024

Study Start

May 21, 2024

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

July 19, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

A case report form for each participant will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations